Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice

被引:32
作者
Chiba, Tsuyoshi [1 ]
Suzuki, Sachina [1 ]
Sato, Yoko [1 ]
Itoh, Tatsuki [2 ]
Umegaki, Keizo [1 ]
机构
[1] Natl Inst Biomed Innovat Hlth & Nutr, Natl Inst Hlth & Nutr, Informat Ctr, Shinjuku Ku, Tokyo, Japan
[2] Kinki Univ, Fac Agr, Dept Food Sci & Nutr, Naka, Nara, Japan
来源
PLOS ONE | 2016年 / 11卷 / 10期
关键词
LIVER-DISEASE; METABOLIC SYNDROME; MODEL; FIBROSIS; MOUSE; INFLAMMATION; PROGRESSION; RESISTANCE; IMPACT; RATS;
D O I
10.1371/journal.pone.0164191
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aim Non-alcoholic steatohepatitis (NASH) is a globally recognized liver disease. A methionine-and choline-deficient diet is used to induce NASH in mice; however, this diet also causes severe body weight loss. To resolve this issue, we examined the effects of methionine content in a high-fat and choline-deficient (HFCD) diet on body weight and the development of NASH in mice. Methods C57BL/6J mice (male, 10 weeks of age) were fed an L-amino acid rodent (control) diet, high-fat (HF) diet, or HFCD diet containing various amounts of methionine (0.1-0.6% (w/w)) for 12 weeks. Plasma lipid levels, hepatic lipid content and inflammatory marker gene expression were measured, and a pathological analysis was conducted to evaluate NASH. Results The 0.1% methionine in HFCD diet suppressed body weight gain, which was lower than that with control diet. On the other hand, the 0.2% methionine in HFCD diet yielded similar body weight gains as the control diet, while more than 0.4% methionine showed the same body weight gains as the HF diet. Liver weights and hepatic lipid contents were the greatest with 0.1% methionine and decreased in a methionine dose-dependent manner. Pathological analysis, NAFLD activity scores and gene expression levels in the liver revealed that 0.1% and 0.2% methionine for 12 weeks induced NASH, whereas 0.4% and 0.6% methionine attenuated the induction of NASH by HFCD diet. However, the 0.2% methionine in HFCD diet did not induce insulin resistance, despite the body weight gain. Conclusions The 0.2% methionine in HFCD diet for 12 weeks was able to induce NASH without weight loss.
引用
收藏
页数:17
相关论文
共 36 条
  • [31] New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease
    Sahebkar, Amirhossein
    Chew, Gerard T.
    Watts, Gerald F.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (04) : 493 - 503
  • [32] Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis
    Salamone, Federico
    Galvano, Fabio
    Marino, Antonella
    Paternostro, Claudia
    Tibullo, Daniele
    Bucchieri, Fabio
    Mangiameli, Andrea
    Parola, Maurizio
    Bugianesi, Elisabetta
    Volti, Giovanni Li
    [J]. DIGESTIVE AND LIVER DISEASE, 2012, 44 (04) : 334 - 342
  • [33] Nonalcoholic Steatohepatitis: A Search for Factual Animal Models
    Sanches, Sheila Cristina L.
    Ramalho, Leandra Naira Z.
    Augusto, Marlei Josiele
    da Silva, Deisy Mara
    Ramalho, Fernando Silva
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [34] Non-alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches
    Schuppan, Detlef
    Schattenberg, Jorn M.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 68 - 76
  • [35] Nonalcoholic steatohepatitis
    Sheth, SG
    Gordon, FD
    Chopra, S
    [J]. ANNALS OF INTERNAL MEDICINE, 1997, 126 (02) : 137 - 145
  • [36] Hepatoprotective Effects of the Dual Peroxisome Proliferator-Activated Receptor Alpha/Delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Staels, Bart
    Rubenstrunk, Anne
    Noel, Benoit
    Rigou, Geraldine
    Delataille, Philippe
    Millatt, Lesley J.
    Baron, Morgane
    Lucas, Anthony
    Tailleux, Anne
    Hum, Dean W.
    Ratziu, Vlad
    Cariou, Bertrand
    Hanf, Remy
    [J]. HEPATOLOGY, 2013, 58 (06) : 1941 - 1952